Lachlan Brown

Stock Analyst at William Blair

(1.89)
# 3,318
Out of 5,090 analysts
11
Total ratings
44.44%
Success rate
4.81%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $32.02
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $179.69
Upside: +11.30%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $45.75
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $5.89
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $12.58
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $466.76
Upside: +28.55%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $337.53
Upside: +3.69%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $23.63
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $92.75
Upside: -2.96%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $83.70
Upside: +162.84%